Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The effective agent in electroconvulsive therapy: convulsion or coma?

D R O'Brien1

  • 1Central Institute of Technology, School of Pharmacy, Trentham, New Zealand.

Medical Hypotheses
|April 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized controlled trials in industrial low back pain relating to return to work. Part 2. Discogenic low back pain.

Archives of physical medicine and rehabilitation·1996
Same author

Randomized controlled trials in industrial low back pain relating to return to work. Part 1. Acute interventions.

Archives of physical medicine and rehabilitation·1995
Same author

Partnering as a key strategy of managing to outcomes.

Hospital materiel management quarterly·1995
Same author

Changing to a new vendor and new hospital information system.

American journal of hospital pharmacy·1993
Same author

Eliminating human immunodeficiency virus (HIV) from infected individuals and cells: is it possible?

Medical hypotheses·1992
Same author

Thyroid dysfunction in individuals with Down syndrome.

Archives of internal medicine·1989

Electrically-induced convulsions, or electroconvulsive therapy (ECT), may work by causing adenosine release during the coma phase, not the seizure. This suggests chemically-induced coma could be a safer alternative for treating mental illness.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Electroconvulsive therapy (ECT) has been used for mental illness for 50 years.
  • The exact cerebral mechanisms behind ECT's therapeutic effects remain unclear.
  • Research has focused on the convulsion aspect of ECT, overlooking the coma phase.

Purpose of the Study:

  • To propose a new hypothesis for the therapeutic effects of electroconvulsive therapy (ECT).
  • To highlight the potential role of the post-convulsive coma in ECT's effectiveness.
  • To suggest alternative treatments based on this hypothesis.

Main Methods:

  • This study presents a theoretical hypothesis.
  • It postulates the release of adenosine (ARN) from neuronal tissue during the convulsion.

Related Experiment Videos

  • It suggests the depressant effect of adenosine on neuronal activity is key.

    • Main Results:

    • The hypothesis posits that adenosine release during the coma following ECT is the primary therapeutic mechanism.
    • This adenosine-mediated neuronal depression could explain the clinical benefits observed.
    • The focus shifts from the convulsion to the coma as the critical therapeutic element.

    Conclusions:

    • The coma phase following electroconvulsive therapy (ECT) may be responsible for its therapeutic effects.
    • Adenosine release during this coma is hypothesized as the key neurochemical mechanism.
    • Chemically-induced coma, especially with benzodiazepines, may offer a safer, effective alternative to ECT for mental illness treatment.